CLPT ClearPoint Neuro: Operating Margin

Corporate emblem and logo of ClearPoint Neuro Inc. (CLPT)

ClearPoint Neuro, Inc. (CLPT) is diversifying its revenue streams by combining neurosurgical navigation with IT solutions and gene therapy. The target operating margin indicates that the current metric is -70.60. The company serves as a technological co-author of precision positioning systems for pharma behemoths and physicians. Meanwhile, production capacities are operating at maximum efficiency, expanding assembly shops to accommodate growing order volumes.

CLPT: ClearPoint Operating Margin 07/04/2022 - 11/19/2026

ClearPoint Neuro Inc. - analytical breakdowns and key metrics (CLPT)

- share price and consensus valuation forecast:
Fundamental company analysis:CLPT, ClearPoint Neuro
Brand item of ClearPoint Neuro

A fundamental search for resilient assets requires an analysis of cost management efficiency. Operating margin measures the share of profit from the core business before financial expenses and taxes, reflecting internal profitability. For ClearPoint Neuro (CLPT), high margins confirm the value of neuronavigation systems, which create an insurmountable barrier for competitors. The efficiency of this technological monopoly directly determines financial stability. By analyzing operating margin fluctuations, an investor can see the company's actual ability to convert innovation into net cash flow.

Competitors of ClearPoint Neuro, Inc. (CLPT)

BSX (Boston Scientific Corporation Inc.) - Operating Margin|Operating Margin Edwards Lifesciences Inc.|Operating Margin RMD|Operating Sales Margin Insulet Corporation PODD|Operating Profitability Zimmer Biomet ZBH|CooperVision - Operating Profitability|ALGN - Operating Profitability|GMED: Operating Profitability|TMDX (TransMedics Corp) - Operating Sales Margin|Alphatec Holdings, Inc. - Operating Profit Rate|AORT (Artivion Corp) - Operating Margin|Operating Return on Sales Enovis Corp ENOV|Operating Profitability Integra LifeSciences Corp (IART)|Establishment Labs (ESTA) - Operating Profitability Margin|iLet Bionic Pancreas - Operating Sales Margin|Operating Margin IRADIMED CORPORATION IRMD|Embecta Corp - Operating Margin|Profitability of Operations Tandem Diabetes Care Inc TNDM|Axogen (AXGN) - Operating Profitability|Operating Profit Margin SIBN (SI-BONE Medical)|Operating Profitability orthofix.com|Operating Return on Sales bioventus.com BVS|Operating Margin KIDS|TMCI - Operating Return on Sales|Operating Profitability Strata Critical Medical Inc SRTA|CARL: Return on Sales by Operating Profit|RXST: Operating Sales Margin|stereotaxis.com - Operating Profit Ratio|NeuroStar (STIM) - Operating Profitability|SGHT - Profitability of Operations|Operating Profitability Orchestra BioMed|Return on Sales by Operating Profit ANIK (Anika Therapeutics)|Operating Profitability inspiremd.com (NSPR)|Jin Medical International Ltd - Return on Sales by Operating Profit|Operating Margin VANI (Vivani Medical Inc)|XTNT: Return on Sales by Operating Profit|NMTC - Operating Profitability|MODD: Operating Profitability|MYO: Operating Margin|envoymedical.com - Operating Profit Rate|Operating Sales Margin VVOS|Operating Return on Sales enVVeno NVNO|Operating Margin SINT|TNON - Operating Return on Sales|Operating Profitability ReWalk Robotics LFWD|AMIX: Return on Sales by Operating Profit|IVF - Operating Profitability|Operating Return on Sales Bone Biologics Corp|AXNX: Operating Margin|Operating Sales Margin BIOLASE, Inc.|Operating Sales Margin DYNT|Operating Sales Margin Paragon 28 (FNA)|Operating Profitability INVO Bio (INVO)